| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2007;38:1850.)
© 2007 American Heart Association, Inc.
Original Contributions |
From the Long Island College Hospital, Department of Neurology, and State University of New York Health Sciences Center, Downstate Campus, Brooklyn, NY (N.J.); the Zeenat Qureshi Stroke Research Center (A.I.Q.), University of Minnesota, Minneapolis, Minn; Columbia University Medical Center (A.N.), Department of Surgery, New York, NY; and the National Institutes of Neurological Disorders and Stroke, Office of Minority Health and Research, National Institutes of Health, Bethesda, Md (J.K.L.)
Correspondence to Dr Nazli Janjua, Long Island College Hospital, Department of Neurology, 339 Hicks St, Brooklyn, NY 11201. E-mail NJanjua{at}chpnet.org
Background and Purpose— Few pediatric reports of thrombolysis exist. We sought to determine national rates of thrombolysis among pediatric ischemic stroke patients using a national database.
Methods— Patients between the ages of 1 and 17 years, entered in the Nationwide Inpatient Sample between 2000 and 2003, with International Classification of Diseases codes for ischemic stroke were included in the study. Differences in mean age, gender distribution, ethnicity, secondary diagnoses, medical complications, associated procedure rates, modes of discharge, and hospital costs between pediatric stroke patients receiving and not receiving thrombolysis were estimated.
Results— In the United States, between 2000 and 2003 an estimated 2904 children were admitted with ischemic stroke, of which 46 children (1.6%) received thrombolytic therapy. Children who received thrombolysis were on the average older (11 versus 9 years), more likely to be male (100% versus 53.8%), with significantly higher hospital costs ($81 800 versus $38 700). These children were also less likely to be discharged home with higher rates of death and dependency, although differences in clinical severity between the 2 groups was not known.
Conclusion— Thrombolysis, though not indicated for patients <18 years of age, is currently being administered to children, with unclear benefit. Larger studies are needed to evaluate the safety and efficacy of this treatment for children.
Key Words: ischemic pediatric stroke thrombolysis
Related Article:
Stroke 2007 38: 1722-1723.
This article has been cited by other articles:
![]() |
P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 887S - 968S. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lo, K. Zamel, K. Ponnappa, A. Allen, D. Chisolm, M. Tang, B. Kerlin, and K. O. Yeates The Cost of Pediatric Stroke Care and Rehabilitation Stroke, January 1, 2008; 39(1): 161 - 165. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |